Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,918.50
Bid: 1,925.50
Ask: 1,927.00
Change: 38.00 (2.02%)
Spread: 1.50 (0.078%)
Open: 1,903.00
High: 1,937.50
Low: 1,887.50
Prev. Close: 1,880.50
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

12 Mar 2014 10:05

UK BROKER RATINGS: Four Brokers Raise Close Brothers Price Target

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
BERENBERG CUTS TRAVIS PERKINS PRICE TARGET TO 1800 (1880) PENCE - 'HOLD'
----------
JEFFERIES CUTS LAND SECURITIES

Read more
12 Mar 2014 09:21

UPDATE 1-Hikma full-year profit doubles on strong doxycycline sales

* Sees 2014 revenue growth of 5 pct * Expects injectibles revenue to rise 20 percent this year * Sees generics revenue of around $170 million in 2014 * FY 2013 revenue rises 23 pct to $1.37 bln * To pay final div of $0.13/shr, special div of $0.04/share March 12 (Reu

Read more
12 Mar 2014 09:03

Wednesday broker round-up UPDATE

Ashtead Group: Citi raises target price from 850p to 1075p keeping a buy recommendation. Barratt Developments: Goldman Sachs reduces target price from 527p to 502p and downgrades to neutral. British Land: Jefferies downgrades to hold with a target price of 707p. Brooks Macdonald Group: Canaccord

Read more
12 Mar 2014 08:45

Hikma Proposes Special Dividend As 2013 Pretax Profit Jumps

LONDON (Alliance News) - Hikma Pharmaceuticals PLC Wednesday proposed a final special dividend and raised its total dividend, as it saw pretax profit jump in 2013. Pretax profit was USD298 million, up from USD132 million in 2012, as revenue rose to USD1.37 billion from USD1.11 billion. <

Read more
12 Mar 2014 08:38

UK MORNING BRIEFING: Share Open Lower But Prudential Gains

LONDON (Alliance News) - Share are lower at the open Wednesday, following Asian and US markets.

Just after the open, insurer Prudential declared a 15% dividend increase for 2013. CEO Tidjane Thiam promised "more of the same, just better". It also announced an expand

Read more
12 Mar 2014 07:45

London pre-open: Potential second Chinese bond default to hit FTSE

- FTSE to open around 60 points lower - Reports of potential second bond default in China - Data out on US Crude Oil Inventories and EU Industrial Production The City is set to start the day firmly in reverse on the back of reports of another bond default in China and a negative finish in the US la

Read more
12 Mar 2014 07:38

MARKET COMMENT: UK Stocks Set To Follow US And Asian Stocks Lower

LONDON (Alliance News) - UK stocks are set to open lower Wednesday, following on from weak sessions in the US and Asia, as investors continue to be starved of significant fresh data releases. Meanwhile, a host of FTSE 100-listed companies have gone ex-dividend which is set to further weigh

Read more
12 Mar 2014 07:31

Hikma full-year profit doubles on strong doxycycline sales

March 12 (Reuters) - Hikma Pharmaceuticals Plc's full-year profit more than doubled helped by strong demand and higher prices for the antibiotic doxycycline that is used in the treatment bacterial infections including Lyme disease. The company, which makes and markets branded and non-brand

Read more
12 Mar 2014 07:07

Hikma Pharma ups dividend as generics generate generous cash - UPDATE

- Revenue and EPS up 23 and 111 per cent - Final and special dividend of 13c and 4c - Growth expected in 2014 despite pullback in generics Powerful revenue growth from its generic drugs and solid growth elsewhere helped Hikma Pharmaceutical post impressive results for 2013. Group revenue increas

Read more
11 Mar 2014 09:03

Tuesday broker round-up UPDATE

Aviva: RBC Capital takes target price from 400p to 550p upgrading to neutral. Nomura increases target price from 489p to 625p and reiterates a buy recommendation. Balfour Beatty: Citi raises target price from 220p to 310p maintaining a neutral rating. Goldman Sachs reduces target price from 335p to

Read more
11 Mar 2014 06:39

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 11 
ComputacenterRead more
10 Mar 2014 15:12

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 11 
ComputacenterRead more
10 Mar 2014 06:34

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Mar 2014 14:55

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Mar 2014 15:44

UK Earnings, Trading Statements Calendar - Week Ahead

Read more

Quickpicks are a member only feature

Login to your account